Medpace Holdings, Inc.
Symboli: MEDP
NASDAQ
392.57
USDMarkkinahinta tänään
38.7448
P/E-suhde
0.0000
PEG-suhde
12.16B
MRK Cap
- 0.00%
DIV Tuotto
Medpace Holdings, Inc. (MEDP) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 1145.4 | 298.4 | 253.4 | 186.4 | ||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.other-current-assets | 234.34 | 50 | 52.3 | 43.2 | ||||||||||
balance-sheet.row.total-current-assets | 2166.54 | 593.8 | 334 | 690.9 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 1036.38 | 265.4 | 248.9 | 222.7 | ||||||||||
balance-sheet.row.goodwill | 2649.58 | 662.4 | 662.4 | 662.4 | ||||||||||
balance-sheet.row.intangible-assets | 144.52 | 35.8 | 38 | 41.4 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2794.11 | 698.2 | 700.4 | 703.8 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.tax-assets | 260.77 | 74.4 | 48.1 | 25.1 | ||||||||||
balance-sheet.row.other-non-current-assets | 88.47 | 25 | 21.1 | 17.4 | ||||||||||
balance-sheet.row.total-non-current-assets | 4179.74 | 1063 | 1018.5 | 969 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.account-payables | 118.9 | 31.9 | 33.1 | 25.7 | ||||||||||
balance-sheet.row.short-term-debt | 885.06 | 293 | 50 | 159.3 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 6.99 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 392.9 | 40.4 | 257.7 | 27.6 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 671.08 | 172.7 | 162.6 | 149.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 560.71 | 142.1 | 138.9 | 131 | ||||||||||
balance-sheet.row.total-liab | 4253.81 | 1097.9 | 966.1 | 707 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 1.23 | 0.3 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.retained-earnings | -1012 | -221.6 | -359.8 | 235 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -46.18 | -10.1 | -12.4 | -4.8 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 3149.41 | 790.4 | 758.3 | 722.4 | ||||||||||
balance-sheet.row.total-stockholders-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6346.28 | 1656.8 | 1352.5 | 1659.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 2092.46 | 559 | 386.4 | 952.9 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6346.28 | - | - | - | ||||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-debt | 615.71 | 142.1 | 188.9 | 131 | ||||||||||
balance-sheet.row.net-debt | -171.1 | -103.3 | 160.6 | -330.3 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 | ||||||||||
cash-flows.row.depreciation-and-amortization | 27.36 | 26.3 | 22.3 | 21.1 | ||||||||||
cash-flows.row.deferred-income-tax | -24.92 | -25.1 | -23 | -37.1 | ||||||||||
cash-flows.row.stock-based-compensation | 19.39 | 20.5 | 21.4 | 14.5 | ||||||||||
cash-flows.row.change-in-working-capital | 151.12 | 106.5 | 106.1 | 66.7 | ||||||||||
cash-flows.row.account-receivables | -24.82 | -48.3 | -66.9 | -25 | ||||||||||
cash-flows.row.inventory | 43.94 | 66.2 | 0 | 25 | ||||||||||
cash-flows.row.account-payables | -10.76 | 1.1 | 6.4 | 1.9 | ||||||||||
cash-flows.row.other-working-capital | 179.05 | 87.5 | 166.5 | 64.8 | ||||||||||
cash-flows.row.other-non-cash-items | 20.52 | 22.4 | 15.9 | 16.3 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 505.98 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 10.04 | 2 | -1.9 | -3.1 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -22.6 | -34.6 | -38.7 | -31.4 | ||||||||||
cash-flows.row.debt-repayment | -130 | -155 | -274.2 | 0 | ||||||||||
cash-flows.row.common-stock-issued | 16.57 | 11.4 | 22.1 | 17.6 | ||||||||||
cash-flows.row.common-stock-repurchased | -23.87 | -144 | -847.8 | -62.1 | ||||||||||
cash-flows.row.dividends-paid | 0 | -11.4 | -22.1 | 0 | ||||||||||
cash-flows.row.other-financing-activites | -23.43 | 116.4 | 346.3 | -44.5 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -122.3 | -182.6 | -775.8 | -44.5 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.99 | 1.1 | -6.6 | -4 | ||||||||||
cash-flows.row.net-change-in-cash | 360.09 | 217.2 | -433 | 183.5 | ||||||||||
cash-flows.row.cash-at-end-of-period | 786.8 | 245.4 | 28.3 | 461.3 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 426.72 | 28.3 | 461.3 | 277.8 | ||||||||||
cash-flows.row.operating-cash-flow | 505.98 | 433.4 | 388.1 | 263.3 | ||||||||||
cash-flows.row.capital-expenditure | -32.63 | -36.6 | -36.9 | -28.3 | ||||||||||
cash-flows.row.free-cash-flow | 473.34 | 396.7 | 351.2 | 235.1 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1962.81 | 1885.8 | 1460 | 1142.4 | ||||||||||
income-statement-row.row.cost-of-revenue | 1413.35 | 1361.3 | 1027.6 | 814.2 | ||||||||||
income-statement-row.row.gross-profit | 549.46 | 524.5 | 432.4 | 328.2 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 41.01 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.operating-expenses | 194.77 | 187.7 | 153.7 | 129.5 | ||||||||||
income-statement-row.row.cost-and-expenses | 1608.12 | 1549 | 1181.3 | 943.8 | ||||||||||
income-statement-row.row.interest-income | 3.31 | 0 | 2.9 | 0.1 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1.5 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 12.98 | 1.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.total-operating-expenses | 1.89 | -0.7 | 4.2 | 3.2 | ||||||||||
income-statement-row.row.interest-expense | 7.43 | -0.5 | 2.9 | -0.1 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 26.08 | 26.3 | 22.3 | 21.1 | ||||||||||
income-statement-row.row.ebitda-caps | 381.37 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 354.69 | 336.8 | 278.7 | 198.6 | ||||||||||
income-statement-row.row.income-before-tax | 362.43 | 335.7 | 282.9 | 201.9 | ||||||||||
income-statement-row.row.income-tax-expense | 49.93 | 52.9 | 37.5 | 20 | ||||||||||
income-statement-row.row.net-income | 312.51 | 282.8 | 245.4 | 181.8 |
Usein kysytty kysymys
Mikä on Medpace Holdings, Inc. (MEDP) taseen loppusumma?
Medpace Holdings, Inc. (MEDP) kokonaisvarat ovat 1656828000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on 1009445000.000.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.280.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 15.347.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.159.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.181.
Mikä on Medpace Holdings, Inc. (MEDP) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 282810000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 142122000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 187680000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 407010000.000.